BIOMAT Database Logo BIOMAT Database Logo

Clinical experiences with nitrogen mustard in Hodgkin's disease. 1947

H O HOFMEYR

UI MeSH Term Description Entries
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D005021 Ethylamines Derivatives of ethylamine (the structural formula CH3CH2NH2).
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

H O HOFMEYR
Clinical experience with nitrogen mustard in Hodgkin's disease.
September 1951, The British journal of radiology,
H O HOFMEYR
Hypogammaglobulinemia in Hodgkin's disease treated with nitrogen mustard.
September 1966, Archives of internal medicine,
H O HOFMEYR
The clinical effect of nitrogen mustard on Hodgkin's disease.
April 1949, American journal of clinical pathology,
H O HOFMEYR
Nitrogen mustard treatment of Hodgkin's disease.
October 1949, Virginia medical monthly,
H O HOFMEYR
[Nitrogen mustard and Hodgkin's disease; case report].
November 1953, Portugal medico,
H O HOFMEYR
A case of Hodgkin's disease treated with nitrogen mustard.
April 1947, West London medical journal,
H O HOFMEYR
Nitrogen mustard therapy with special reference to Hodgkin's disease.
September 1949, British medical journal,
H O HOFMEYR
[Clinical studies on nitrogen mustard and roentgen therapy of Hodgkin's disease].
January 1959, Tumori,
H O HOFMEYR
Experiences with nitrogen mustard therapy.
March 1949, Journal of the American Medical Association,
H O HOFMEYR
Vinblastine vs. nitrogen mustard therapy of Hodgkin's disease.
August 1968, Cancer,
Copied contents to your clipboard!